There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
When administered in conjunction with primary coronary stenting for the treatment
of acute myocardial infarction, a platelet glycoprotein IIb/IIIa inhibitor may provide
additional clinical benefit, but data on this combination therapy are limited.